Mutations in binding sites can alter their shape and function, affecting how well they can interact with other molecules. For instance, a mutation in the binding site of a tumor suppressor protein like p53 might prevent it from binding to DNA and activating genes that inhibit cell division, leading to cancer progression. Similarly, mutations in the binding sites of oncoproteins can make them resistant to drugs designed to inhibit their activity.
